Dermatological treatment developer Dermira has now raised $128m, with pharmaceutical company UCB joining Maruho as a corporate backer.

The corporates contributed to a series C round raised by mobile payments company SumUp, which is also backed by Tengelmann and American Express.

Nutrinsic Corporation has completed a $12.7 million capital raise that will support the continued growth of its nutrient-recycling technology.

Farm management company Agworld has secured $5.6m in a series B round led by Reed Elsevier that took its overall funding to $11.2m.

Johnson & Johnson-backed ViaCyte raised $5.4m through a sale of series C-1 preferred stock, with proceeds to fund development of its diabetes treatment.

Bertelsmann-backed Mo9 raised an eight-figure dollar round from undisclosed backers.

Memory card producer Memblaze has raised $20m in a series C round featuring the Asia-focused investment arm of publisher Bertelsmann.

Intel and Juniper Networks participated in the round as new investors, taking the cybersecurity company's overall funding to approximately $43m.

The pharmaceutical companies have reinvested in Epic Sciences, which has raised $30m to fund commercialisation of its cancer cell testing technology.